NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-137-2018-2-CN-06 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response CN National Stage 201880030232.8 Pending
NIAID E-137-2018-2-CA-05 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response CA National Stage 3057715 Pending
NIAID E-137-2018-2-KR-12 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response KR National Stage 10-2019-7032483 Pending
NIAID E-137-2018-2-MX-13 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response MX National Stage MX/a/2019/011888 Pending
NIAID E-137-2018-2-JP-11 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response JP National Stage 2019-555006 Abandoned
NCATS E-130-2017-0-PCT-02 Target JAK2/IL11-mediated Pathway By LY2784544 To Treat Platinum Drug Resistant Ovarian Cancer PCT PCT PCT/US2018/026106 Expired
NIAID E-137-2018-2-BR-04 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response BR National Stage BR1120190208534 Pending
NIAID E-137-2018-2-AU-03 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response AU National Stage 2018250226 Pending
NIAID E-137-2018-2-EP-08 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response EP National Stage 18724006.4 Pending
NIAID E-137-2018-2-IL-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response IL DIV 302880 Pending
NIAID E-137-2018-2-IN-10 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response IN National Stage 201917040040 Pending
NHLBI E-273-2015-0-IE-09 Endo-cameral Closure Device IE EP 16852768.7 Issued
NHLBI E-273-2015-0-CH-05 Endo-cameral Closure Device CH EP 16852768.7 Issued
NHLBI E-273-2015-0-GB-08 Endo-cameral Closure Device GB EP 16852768.7 Issued
NHLBI E-273-2015-0-FR-07 Endo-cameral Closure Device FR EP 16852768.7 Issued
NHLBI E-273-2015-0-DE-06 Endo-cameral Closure Device DE EP 16852768.7 Issued
NHLBI E-273-2015-0-EP-03 Endo-cameral Closure Device EP National Stage 16852768.7 Issued
NHLBI E-287-2015-2-EP-04 Devices And Methods For Effectuating Percutaneous Glenn And Fontan Procedures EP National Stage 16847336.1 Issued
NCI E-277-2016-0-PCT-02 Functionally-interdependent Shape-switching Nucleic Acid Nanoparticles PCT PCT PCT/US2018/025953 Expired
NHLBI E-165-2015-2-US-01 LENTIVIRAL PROTEIN DELIVERY SYSTEM FOR RNA-GUIDED GENOME EDITING US CIP 15/942,673 11203768 Issued PDF
NCI E-237-2016-0-PCT-02 EXPRESSION CASSETTES AND METHODS FOR DETECTING TRANSCRIPTION ERRORS PCT PCT PCT/US2018/025701 Expired
NCI E-040-2012-0-RU-26 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen RU DIV 2018111462 Issued
NCI E-171-2017-0-PCT-02 B CELL DISORDER CLASSIFICATION AND SUSCEPTIBILITY TO INHIBITORS PCT PCT PCT/US2018/025377 Expired
NCI E-244-2015-0-CN-05 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use CN National Stage 201680057188.0 Issued
NCATS E-060-2017-3-US-02 Compositions And Methods For Identifying And Treating Dystonia Disorders US National Stage 15/764,320 11285142 Issued PDF
NCATS E-257-2010-0-CH-49 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CH EP 18165005.2 Issued
NCATS E-257-2010-0-TR-69 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators TR EP 18165005.2 Issued
NCATS E-257-2010-0-GB-56 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GB EP 18165005.2 Issued
NCATS E-257-2010-0-PL-64 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PL EP 18165005.2 Issued
NCATS E-257-2010-0-RO-66 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators RO EP 18165005.2 Issued
NCATS E-257-2010-0-NO-63 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NO EP 18165005.2 Issued
NCATS E-257-2010-0-PT-65 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PT EP 18165005.2 Issued
NCATS E-257-2010-0-ES-53 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators ES EP 18165005.2 Issued
NCATS E-257-2010-0-SE-67 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SE EP 18165005.2 Issued
NCATS E-257-2010-0-SK-68 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SK EP 18165005.2 Issued
NCATS E-257-2010-0-RS-78 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators RS EP 18165005.2 Issued
NCATS E-257-2010-0-SI-79 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SI EP 18165005.2 Issued
NCATS E-257-2010-0-HU-58 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators HU EP 18165005.2 Issued
NCATS E-257-2010-0-IE-59 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IE EP 18165005.2 Issued
NCATS E-257-2010-0-IT-60 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IT EP 18165005.2 Issued
NCATS E-257-2010-0-GR-57 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GR EP 18165005.2 Issued
NCATS E-257-2010-0-IS-73 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IS EP 18165005.2 Issued
NCATS E-257-2010-0-EE-71 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EE EP 18165005.2 Issued
NCATS E-257-2010-0-DK-52 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators DK EP 18165005.2 Issued
NCATS E-257-2010-0-CZ-50 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CZ EP 18165005.2 Issued
NCATS E-257-2010-0-CY-70 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CY EP 18165005.2 Issued
NCATS E-257-2010-0-HR-72 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators HR EP 18165005.2 Issued
NCATS E-257-2010-0-EP-18 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EP DIV 18165005.2 Issued
NCATS E-257-2010-0-LI-61 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LI EP 18165005.2 Issued
NCATS E-257-2010-0-LU-75 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LU EP 18165005.2 Issued